FibroBiologics: Funding, Investors & Team (Sep 2026)
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive approach to treat chronic diseases using fibroblast cells. Their innovative research spans across several clinical pathways such as Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer, and is supported by over 150 U.S. and International patents that have either been issued or are still pending. FibroBiologics' work stands as a testament to the development of cell therapy and represents the future of medical advancement.
FibroBiologics has raised $114M across 6 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Jun 2026.
That round is in line with the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
FibroBiologics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
FibroBiologics Funding Rounds
FibroBiologics raised $100M in a Private Equity announced in Nov 2021.
1.3 years later, an undisclosed round of $5.0M was announced in Mar 2023.
2.7 years later, an undisclosed round of $1.5M was announced in Nov 2025.
1 month later, an undisclosed round of $1.7M was announced in Dec 2025.
3 months later, an undisclosed round of $3.0M was announced in Mar 2026.
3 months later, an undisclosed round of $3.0M was announced in Jun 2026.
FibroBiologics Founders and Leadership Team
Contact details for the FibroBiologics team: 1 of 1 has an email address on file.
Start 14-day free trial →FibroBiologics Funding Compared to Other Biotechnology Research Startups
FibroBiologics' latest round of $3.0M is in line with the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FibroBiologics in Biotechnology Research and Houston
Companies Similar to FibroBiologics
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2…
Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when…
Empatica is a startup that specializes in emotional computing and human data analytics. We create…
Cybele utilizes unique technology to deliver high-effective solutions for human health.
FibroBiologics Funding FAQs
What does FibroBiologics do?
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive approach to treat chronic diseases using fibroblast cells. Their innovative research spans across several clinical pathways such as Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer, and is supported by over 150 U.S. and International patents that have either been issued or are still pending. FibroBiologics' work stands as a testament to the development of cell therapy and represents the future of medical advancement.
How much funding has FibroBiologics raised?
FibroBiologics has raised $114M across 6 rounds on record. The most recent is an undisclosed round of $3.0M announced in Jun 2026.
When did FibroBiologics last raise funding?
FibroBiologics' most recent funding round on record is an undisclosed round of $3.0M, announced in Jun 2026.
Who is the CEO of FibroBiologics?
Pete O'heeron is listed as CEO at FibroBiologics.
Where is FibroBiologics headquartered?
FibroBiologics is based in Houston, Texas, United States.
How many employees does FibroBiologics have?
FibroBiologics is in the 11-50 employee band.
How does FibroBiologics' funding compare to other Biotechnology Research startups?
FibroBiologics' latest round of $3.0M is in line with the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's FibroBiologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FibroBiologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.